ArticleThe Journal of clinical investigation2024

Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.

Guo Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.